Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The autophagy degradation machinery is a highly conserved catabolic process responsible for the degradation and recycling of cytoplasmic components, including damaged organelles and misfolded proteins, via the lysosomal pathway [Mizushima et al., 2011, Cell]. This machinery is orchestrated by a series of autophagy-related (ATG) proteins that facilitate the formation of double-membrane vesicles called autophagosomes, which subsequently fuse with lysosomes for cargo digestion [Dikic & Elazar, 2018, Nat Rev Mol Cell Biol]. It serves as a critical quality control mechanism, maintaining cellular homeostasis under basal conditions and providing energy during nutrient deprivation [Levine & Kroemer, 2019, Cell]. Dysregulation of this machinery is implicated in a wide range of pathologies, including neurodegenerative diseases where protein aggregates accumulate, and cancer, where it plays a dual role as both a tumor suppressor and a survival mechanism for established tumors [Galluzzi et al., 2017, Nat Rev Drug Discov]. Therapeutic strategies involve either inducing autophagy to clear toxic aggregates or inhibiting it to sensitize cancer cells to chemotherapy [Klionsky et al., 2021, Autophagy].
Modulation of the autophagy pathway through mTOR inhibition (induction), PI3K inhibition (blockade of initiation), or lysosomal acidification blockade (blockade of degradation).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Autophagy degradation machinery.